Tilray Brands, Inc. (NASDAQ: TLRY) seeks more time from Nasdaq to restore compliance with per-share price rules, signaling potential shareholder-approved reverse stock split. Company evaluating capital-structure options, including reverse split, to ensure adherence to Nasdaq standards. CEO cites recent trading strength following President Trump’s review of cannabis rescheduling. Tilray’s medical business in Europe shows momentum with new distribution alliance in Italy. TLRY shares down 6.12% to $1.170. Extension request highlights effort to maintain Nasdaq listing amid market volatility and evolving U.S. policy signals.

Read more at Yahoo Finance: Tilray Eyes Reverse Stock Split As Nasdaq Listing Compliance Pressure Mounts